Mark Elliott Boulding - Net Worth and Insider Trading
Mark Elliott Boulding Net Worth
The estimated net worth of Mark Elliott Boulding is at least $4 Million dollars as of 2024-12-26. Mark Elliott Boulding is the EXEC. VP AND CLO of PTC Therapeutics Inc and owns about 92,389 shares of PTC Therapeutics Inc (PTCT) stock worth over $4 Million. Details can be seen in Mark Elliott Boulding's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Elliott Boulding has not made any transactions after 2024-12-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Elliott Boulding
Mark Elliott Boulding Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Elliott Boulding owns 1 companies in total, including PTC Therapeutics Inc (PTCT) .
Click here to see the complete history of Mark Elliott Boulding’s form 4 insider trades.
Insider Ownership Summary of Mark Elliott Boulding
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 2024-12-03 | Exec. VP and CLO |
Mark Elliott Boulding Latest Holdings Summary
Mark Elliott Boulding currently owns a total of 1 stock. Mark Elliott Boulding owns 92,389 shares of PTC Therapeutics Inc (PTCT) as of December 3, 2024, with a value of $4 Million.
Latest Holdings of Mark Elliott Boulding
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 2024-12-03 | 92,389 | 45.35 | 4,189,841 |
Holding Weightings of Mark Elliott Boulding
Mark Elliott Boulding Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Elliott Boulding has made a total of 19 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in PTC Therapeutics Inc is the sale of 95,908 shares on December 3, 2024, which brought Mark Elliott Boulding around $5 Million.
Insider Trading History of Mark Elliott Boulding
- 1
Mark Elliott Boulding Trading Performance
Mark Elliott Boulding Ownership Network
Mark Elliott Boulding Owned Company Details
What does PTC Therapeutics Inc do?
Who are the key executives at PTC Therapeutics Inc?
Mark Elliott Boulding is the Exec. VP and CLO of PTC Therapeutics Inc. Other key executives at PTC Therapeutics Inc include EVP Research Pharma Ops & Tech Neil Gregory Almstead , Principal Financial Officer Christine Marie Utter , and CHIEF FINANCIAL OFFICER Pierre Gravier .
PTC Therapeutics Inc (PTCT) Insider Trades Summary
Over the past 18 months, Mark Elliott Boulding made 3 insider transaction in PTC Therapeutics Inc (PTCT) with a net sale of 100,097. Other recent insider transactions involving PTC Therapeutics Inc (PTCT) include a net sale of 22,455 shares made by Matthew B. Klein , a net sale of 75,166 shares made by Neil Gregory Almstead , and a net sale of 20,959 shares made by Christine Marie Utter .
In summary, during the past 3 months, insiders sold 209,318 shares of PTC Therapeutics Inc (PTCT) in total and bought 0 shares, with a net sale of 209,318 shares. During the past 18 months, 295,600 shares of PTC Therapeutics Inc (PTCT) were sold and 7,700 shares were bought by its insiders, resulting in a net sale of 287,900 shares.
PTC Therapeutics Inc (PTCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
PTC Therapeutics Inc Insider Transactions
Mark Elliott Boulding Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Elliott Boulding. You might contact Mark Elliott Boulding via mailing address: C/o Ptc Therapeutics, Inc., 100 Corporate Court, South Plainfield Nj 07080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
